Neurocrine Biosciences Revenue 2010-2022 | NBIX
Neurocrine Biosciences annual/quarterly revenue history and growth rate from 2010 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Neurocrine Biosciences revenue for the quarter ending March 31, 2022 was $0.311B, a 31.28% increase year-over-year.
- Neurocrine Biosciences revenue for the twelve months ending March 31, 2022 was $1.208B, a 15.51% increase year-over-year.
- Neurocrine Biosciences annual revenue for 2021 was $1.134B, a 8.38% increase from 2020.
- Neurocrine Biosciences annual revenue for 2020 was $1.046B, a 32.71% increase from 2019.
- Neurocrine Biosciences annual revenue for 2019 was $0.788B, a 74.67% increase from 2018.
Neurocrine Biosciences Annual Revenue
(Millions of US $) |
| 2021 |
$1,134 |
| 2020 |
$1,046 |
| 2019 |
$788 |
| 2018 |
$451 |
| 2017 |
$162 |
| 2016 |
$15 |
| 2015 |
$20 |
| 2014 |
$ |
| 2013 |
$3 |
| 2012 |
$53 |
| 2011 |
$77 |
| 2010 |
$34 |
| 2009 |
$3 |
Neurocrine Biosciences Quarterly Revenue
(Millions of US $) |
| 2022-03-31 |
$311 |
| 2021-12-31 |
$312 |
| 2021-09-30 |
$296 |
| 2021-06-30 |
$289 |
| 2021-03-31 |
$237 |
| 2020-12-31 |
$248 |
| 2020-09-30 |
$259 |
| 2020-06-30 |
$302 |
| 2020-03-31 |
$237 |
| 2019-12-31 |
$244 |
| 2019-09-30 |
$222 |
| 2019-06-30 |
$184 |
| 2019-03-31 |
$138 |
| 2018-12-31 |
$131 |
| 2018-09-30 |
$152 |
| 2018-06-30 |
$97 |
| 2018-03-31 |
$71 |
| 2017-12-31 |
$95 |
| 2017-09-30 |
$61 |
| 2017-06-30 |
$6 |
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
$15 |
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
$20 |
| 2014-12-31 |
|
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
$1 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$22 |
| 2012-09-30 |
$9 |
| 2012-06-30 |
$11 |
| 2012-03-31 |
$11 |
| 2011-12-31 |
$11 |
| 2011-09-30 |
$42 |
| 2011-06-30 |
$12 |
| 2011-03-31 |
$13 |
| 2010-12-31 |
$14 |
| 2010-09-30 |
$14 |
| 2010-06-30 |
$5 |
| 2010-03-31 |
$1 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$8.237B |
$1.134B |
|
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
|
